半胱氨酰白三烯激活ATF-2上调VCAM-1表达促进肺预转移小生境形成的机制研究
批准号:
82103398
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
李冉冉
依托单位:
学科分类:
肿瘤微环境
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
李冉冉
中文摘要
肺预转移小生境形成是肿瘤发生肺转移的重要步骤。炎症反应是预转移小生境的特征之一。半胱氨酰白三烯在预转移小生境中表达升高,促进肿瘤转移。但是,半胱氨酰白三烯对预转移小生境形成的影响尚不清楚。我们前期发现:预转移小生境中VCAM-1表达升高。研究表明,半胱氨酰白三烯上调血管内皮细胞表面的VCAM-1。VCAM-1介导白细胞与内皮细胞黏附,促进炎症反应。我们推测:半胱氨酰白三烯通过激活ATF-2上调VCAM-1表达,促进炎症反应,诱导预转移小生境形成。本项目以肺转移动物模型和HUVEC为研究对象,拟采用血管通透性实验、癌细胞渗出实验、免疫共沉淀、基因敲低和过表达等技术研究半胱氨酰白三烯对预转移小生境的影响及机制,并探讨c-Jun、c-Fos、NF-κB是否与ATF-2共同促进VCAM-1表达。本项目将为以半胱氨酰白三烯为靶点防治肿瘤转移提供依据,并揭示ATF-2上调VCAM-1表达的机制。
英文摘要
The formation of lung pre-metastatic niche is a critical step of lung metastasis. Inflammation is one of the characteristics of pre-metastatic niche. The level of cysteinyl leukotrienes (cys-LTs) is elevated in the pre-metastatic niche and it promotes tumor metastasis. But the effect of cys-LTs on the formation of pre-metastatic niche remains unclear. We previously found that the expression of vascular cell adhesion molecule-1 (VCAM-1) was increased in the pre-metastatic niche. It was reported that cys-LTs promoted the expression of VCAM-1 on the surface of vascular endothelial cells. VCAM-1 mediates the adhesion between leukocytes and endothelial cells, and promotes inflammation. We speculate that cys-LTs may activate ATF-2 to induce VCAM-1 expression then promote the formation of lung pre-metastatic niche. In vivo, the 4T1 breast cancer cells and Balb/c mice were used to establish animal models. In vitro, HUVEC is used as the research materials. The technology of vascular permeability assay, cancer cell exudation assay, immunoprecipitation, gene knockdown and overexpression were employed to study the effect and mechanism of cys-LTs on the formation of pre-metastatic niche. We will also explore whether ATF-2 promote VCAM-1 expression cooperate with c-Jun, c-Fos and NF-κB. Our project will provide new ideas for the prevention and treatment of tumor metastasis with cys-LTs as the target, and further explore the mechanism of ATF-2 promotes VCAM-1 expression.
乳腺癌是发病率最高的女性恶性肿瘤,肺是乳腺癌最常见的转移靶器官之一。肺预转移小生境的形成是肿瘤发生肺转移的重要步骤。研究表明,高表达cysLT1R并且低表达cysLT2R的乳腺癌患者生存率低。因此,cys-LTs合成抑制剂或受体拮抗剂可能是治疗乳腺癌肺转移的有效药物。本研究首先用4T1乳腺癌细胞建立了预转移小生境动物模型,并用ELISA检测了预转移阶段小鼠肺组织及血清中的LTB4及LTC4/D4/E4水平。其次用cys-LTs受体抑制剂处理4T1荷瘤小鼠,观察cys-LTs受体抑制剂对预转移阶段小鼠肺组织中炎症反应的影响以及在转移阶段小鼠肺转移瘤数目的影响。随后,我们应用免疫荧光的方法检测了预转移阶段小鼠肺组织中巨噬细胞上PD-L1的表达。最后,我们在体内实验中探讨了cys-LTs是否促进巨噬细胞中PD-L1的表达以及可能的下游机制。我们的研究将为以cys-LTs合成抑制剂或受体拮抗剂为基础研发抗肿瘤药物提供理论依据。
国内基金
海外基金